← Back to Search

Prosthesis

An Osseoanchored Percutaneous Prosthesis Study Evaluating Stable Neural Signal Transmission in Subjects With Transhumeral Amputations

N/A
Waitlist Available
Led By Paul Cederna, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months post-op
Awards & highlights
No Placebo-Only Group

Summary

This early feasibility study proposes to evaluate use of the electronic-Osseoanchored Prostheses for the Rehabilitation of Amputees (e-OPRA) device, a transhumeral implant system for direct skeletal anchorage of amputation prostheses, with a test prosthesis. The e-OPRA System is being investigated to better understand the ability to improve the functionality of the prosthesis and enhance the sense of embodiment of the prosthesis itself. This will be a 10 subject Early Feasibility Study in which the primary objective is to capture preliminary safety and effectiveness information on the implanted e-OPRA system. With the addition of electrodes to the muscle segments, this biological interface allows for both the extraction of fine motor control signals from the nerve fascicles and the generation of sensory percepts via electrical stimulation of the muscles. In addition, electrodes placed on muscles within the residuum with native vascularization and innervation also allow the extraction of critical motor control signals and the generation of sensory feedback through muscle stimulation. The electrical activity recorded from these muscle segments (called electromyography or EMG) is specific to certain movements and can be used to determine precisely how a person wants to move their arm and hand. Use of the e-OPRA device with the well-documented neuro-electronic capabilities of EMG control systems provides an alternative to traditional socket prostheses by establishing a direct, loadbearing link between the patient's skeleton and prosthesis.

Eligible Conditions
  • Amputation
  • Prosthesis User
  • Neuroma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months post-op for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Events
Change in Electrical signal quality between implanted electrodes and test prosthesis
Secondary study objectives
Change in Pain Level as measured by DVPRS (Defense and Veterans Pain Rating Scale)
Change in Pain Level as measured by LANSS surveys
Change in Pain Level as measured by PROMIS (Patient Reported Outcomes Measurement Information System) Questionnaire
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Trasnhumeral e-OPRA ImplantExperimental Treatment1 Intervention
This arm includes patients with transhumeral amputation that will receive the e-OPRA implant system.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER
2,593 Previous Clinical Trials
14,887,950 Total Patients Enrolled
University of MichiganLead Sponsor
1,863 Previous Clinical Trials
6,441,531 Total Patients Enrolled
Paul Cederna, MDPrincipal InvestigatorUniversity of Michigan, Section of Plastic Surgery
~0 spots leftby Dec 2025